QCM
NRIX icon

Quantinno Capital Management’s Nurix Therapeutics NRIX Stock Holding History

Quantinno Capital Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$801K Buy
32,998
+10,865
+49% +$185K ﹤0.01% 2729
2026
Q1 		$343K Buy
22,133
+5,366
+32% +$89K ﹤0.01% 2959
2025
Q4 		$318K Buy
16,767
+163
+1% +$2.34K ﹤0.01% 2796
2025
Q3 		$153K Buy
+16,604
New +$172K ﹤0.01% 2828

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quantinno Capital Management's NRIX Position: Q2 2026 in Review

Quantinno Capital Management increased its Nurix Therapeutics (NRIX) stake by 49% in Q2 2026, buying an estimated $185K and bringing the position to 32,998 shares worth $801K. The position accounts for ﹤0.01% of the portfolio, ranked #2729.

Quantinno Capital Management first reported a position in NRIX in Q3 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Quantinno Capital Management held 32,998 shares of Nurix Therapeutics worth $801K as of Q2 2026.
  • Quantinno Capital Management bought 10,865 Nurix Therapeutics shares in Q2 2026, an estimated $185K.
  • Nurix Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2729 holding.
  • Quantinno Capital Management first reported a position in Nurix Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.